United Kingdom

People: CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

14 Jun 2019
Change (% chg)

$-0.99 (-2.24%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

George, Simeon 

Dr. Simeon J. George, M.D., has been Independent Director of CRISPR Therapeutics Ltd since April 2015. He joined SR One in 2007 and leads SR One’s investment activities on the West Coast. Prior to joining SR One, he was a consultant at Bain & Company and an investment banker at Goldman Sachs and Merrill Lynch. He received his B.A. in neuroscience from the Johns Hopkins University, where he graduated Phi Beta Kappa. He received his M.D. from the University of Pennsylvania School of Medicine and his MBA (Mayer Scholar) from the University of Pennsylvania Wharton School.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --